Recent News for IFRX - InflaRx N.V.

Date Title
Oct 2 The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data
Oct 1 The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines
Sep 5 DOCU, DOMO, SAIC and TSEM among notable after hours movers
Aug 27 ChemoCentryx And InflaRx In Complement-Mediated Pathology: The Collateral Damage
Aug 14 InflaRx reports Q2 results
Aug 14 InflaRx Reports Second Quarter 2019 Financial & Operating Results
Aug 13 Stocks That Hit 52-Week Lows On Tuesday
Aug 6 The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
Jul 30 45 Healthcare Stocks Moving In Monday's After-Market Session
Jul 22 35 Stocks Moving In Monday's Pre-Market Session
Jul 19 Do Insiders Own Shares In InflaRx N.V. (NASDAQ:IFRX)?
Jul 18 SKX, QEP, GCI and OZK among notable after hour movers
Jul 18 InflaRx up 6% after hours on additional IFX-1 data
Jul 18 InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa
Jun 30 Hedge Funds Have Never Been This Bullish On InflaRx N.V. (IFRX)
Jun 13 InflaRx Enters Oversold Territory
Jun 13 InflaRx up 7% premarket on start of IFX-1 study in rare skin disorder
Jun 13 InflaRx Treats First Patient in Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum
Jun 10 MNKD, DATA among premarket gainers
Jun 8 InflaRx Tanks 91.79% As IFX-1 Phase II Trial Flops, Provides Bargain Buy For Competitor ChemoCentryx
Jun 6 CIEN, CTRV among premarket gainers
Jun 6 Benzinga's Top Upgrades, Downgrades For June 6, 2019
Jun 6 The Daily Biotech Pulse: Takeda Pulls Plug On Amyloidosis Drug Trial, Chiasma Preps For Drug Launch With New CEO Appointment, Orchard Prices Offering
Jun 5 Stitch Fix leads after hour movers
Jun 5 InflaRx shares plummet over 90% after drug test failure
Back to the Main IFRX Page...